Myomo Valuation
| MYO Stock | USD 5.19 0.12 2.37% |
At this time, the firm appears to be undervalued. Myomo Inc secures a last-minute Real Value of $6.53 per share. The latest price of the firm is $5.19. Our model forecasts the value of Myomo Inc from analyzing the firm fundamentals such as Profit Margin of (0.19) %, return on equity of -0.37, and Current Valuation of 161.68 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Myomo's price fluctuation is relatively risky at this time. Calculation of the real value of Myomo Inc is based on 3 months time horizon. Increasing Myomo's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Myomo is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Myomo Stock. However, Myomo's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.19 | Real 6.53 | Hype 5.2 | Naive 5.86 |
The intrinsic value of Myomo's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Myomo's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Myomo Inc helps investors to forecast how Myomo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Myomo more accurately as focusing exclusively on Myomo's fundamentals will not take into account other important factors: Myomo Total Value Analysis
Myomo Inc is now anticipated to have company total value of 161.68 M with market capitalization of 178.44 M, debt of 8.11 M, and cash on hands of 5.35 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Myomo fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
161.68 M | 178.44 M | 8.11 M | 5.35 M |
Myomo Investor Information
About 59.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.16. Myomo Inc last dividend was issued on the 31st of January 2020. The entity had 1:30 split on the 31st of January 2020. Based on the analysis of Myomo's profitability, liquidity, and operating efficiency, Myomo Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Myomo Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Myomo has an asset utilization ratio of 77.06 percent. This suggests that the Company is making $0.77 for each dollar of assets. An increasing asset utilization means that Myomo Inc is more efficient with each dollar of assets it utilizes for everyday operations.Myomo Ownership Allocation
Myomo Inc maintains a total of 34.38 Million outstanding shares. Over half of Myomo's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Myomo Profitability Analysis
The company reported the last year's revenue of 32.55 M. Reported Net Loss for the year was (6.18 M) with profit before taxes, overhead, and interest of 23.19 M.About Myomo Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Myomo Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Myomo Inc based exclusively on its fundamental and basic technical indicators. By analyzing Myomo's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Myomo's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Myomo. We calculate exposure to Myomo's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Myomo's related companies.Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. Myomo operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 87 people.
Myomo Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 37.8 M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.